PATENT CLAIM ANALYSIS

Application Number: 16001569
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["702", "019000"]

Abstract:
Disclosed herein is a system and methods for determining the alleles, neoantigens, and vaccine composition as determined on the basis of an individual's tumor mutations. Also disclosed are systems and methods for obtaining high quality sequencing data from a tumor. Further, described herein are systems and methods for identifying somatic changes in polymorphic genome data. Finally, described herein are unique cancer vaccines.

Claim (Index 3):
The method of  claim 1 , wherein the peptide sequences comprise peptide sequences having lengths of 8 or 10-15 amino acids.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 94.0
- Lexical Diversity: 1.47917
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15466729', '15210489', '15170919', '15791301', '13640989']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.247983524814338
- 35 USC 102 Novelty (BERT): 0.640249019182509
- Combined Prediction Score: 0.2872100742511551
- Mean Citation Score: 382.58593
- Max Citation Score: 726.4492
- Similarity Product: 551.6848415105819

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test